Xu, M.; Antonova, M.; Salavei, P.; Illek, K.; Meléndez, A.V.; Omidvar, R.; Thuenauer, R.; Makshakova, O.; Römer, W.
Dimeric Lectin Chimeras as Novel Candidates for Gb3-Mediated Transcytotic Drug Delivery through Cellular Barriers. Pharmaceutics 2023, 15, 225.
https://doi.org/10.3390/pharmaceutics15010225
AMA Style
Xu M, Antonova M, Salavei P, Illek K, Meléndez AV, Omidvar R, Thuenauer R, Makshakova O, Römer W.
Dimeric Lectin Chimeras as Novel Candidates for Gb3-Mediated Transcytotic Drug Delivery through Cellular Barriers. Pharmaceutics. 2023; 15(1):225.
https://doi.org/10.3390/pharmaceutics15010225
Chicago/Turabian Style
Xu, Maokai, Maria Antonova, Pavel Salavei, Katharina Illek, Ana Valeria Meléndez, Ramin Omidvar, Roland Thuenauer, Olga Makshakova, and Winfried Römer.
2023. "Dimeric Lectin Chimeras as Novel Candidates for Gb3-Mediated Transcytotic Drug Delivery through Cellular Barriers" Pharmaceutics 15, no. 1: 225.
https://doi.org/10.3390/pharmaceutics15010225
APA Style
Xu, M., Antonova, M., Salavei, P., Illek, K., Meléndez, A. V., Omidvar, R., Thuenauer, R., Makshakova, O., & Römer, W.
(2023). Dimeric Lectin Chimeras as Novel Candidates for Gb3-Mediated Transcytotic Drug Delivery through Cellular Barriers. Pharmaceutics, 15(1), 225.
https://doi.org/10.3390/pharmaceutics15010225